Skip to main content
SpringerLink
Log in

Diabetes Mellitus and Hypertension

  • Chapter
  • First Online:
Disorders of Blood Pressure Regulation

Part of the book series: Updates in Hypertension and Cardiovascular Protection ((UHCP))

Abstract

Primary hypertension and diabetes mellitus are often coexisting chronic conditions, in the background of obesity and the metabolic syndrome. When untreated, or insufficiently treated, both diseases predispose to renal and cardiovascular morbidity and mortality.

The interplay between hypertension and diabetes mellitus is fascinating and hotly debated, especially when considering blood pressure treatment goals and the choice of agents used to lower blood pressure. In addition, new medication classes introduced to lower blood glucose also demonstrate blood pressure-lowering effects. These provide the practicing clinician more therapeutic tools but also add to treatment complexity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Navar-Boggan AM, Pencina MJ, Williams K, Sniderman AD, Peterson ED (2014) Proportion of US adults potentially affected by the 2014 hypertension guideline. JAMA 311(14):1424–1429

    Article  CAS  PubMed  Google Scholar 

  2. Chobanian AV, Bakris GL, Black HR et al (2003) The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289(19):2560–2572

    Article  CAS  PubMed  Google Scholar 

  3. James PA, Oparil S, Carter BL et al (2014) 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311(5):507–520

    Article  CAS  PubMed  Google Scholar 

  4. (1993) Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens 11(3):309–317

    Google Scholar 

  5. Parving HH, Hommel E, Mathiesen E et al (1988) Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br Med J (Clin Res Ed) 296(6616):156–160

    Article  CAS  Google Scholar 

  6. Hemmingsen B, Lund SS, Gluud C et al (2013) Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Cochrane Database Syst Rev 11:CD008143

    Google Scholar 

  7. Modan M, Halkin H, Almog S et al (1985) Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. J Clin Invest 75(3):809–817

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Stamler R, Stamler J, Riedlinger WF et al (1978) Weight and blood pressure. Findings in hypertension screening of 1 million Americans. JAMA 240(15):1607–1610

    Article  CAS  PubMed  Google Scholar 

  9. Havlik RJ, Hubert HB, Fabsitz RR, Feinleib M (1983) Weight and hypertension. Ann Intern Med 98(5 Pt 2):855–859

    Article  CAS  PubMed  Google Scholar 

  10. Epstein M, Sowers JR (1992) Diabetes mellitus and hypertension. Hypertension 19(5):403–418

    Article  CAS  PubMed  Google Scholar 

  11. Nosadini R, Sambataro M, Thomaseth K et al (1993) Role of hyperglycemia and insulin resistance in determining sodium retention in non-insulin-dependent diabetes. Kidney Int 44(1):139–146

    Article  CAS  PubMed  Google Scholar 

  12. Randeree HA, Omar MA, Motala AA, Seedat MA (1992) Effect of insulin therapy on blood pressure in NIDDM patients with secondary failure. Diabetes Care 15(10):1258–1263

    Article  CAS  PubMed  Google Scholar 

  13. Cruickshank K, Riste L, Anderson SG et al (2002) Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 106(16):2085–2090

    Article  PubMed  Google Scholar 

  14. Gaede P, Vedel P, Parving HH, Pedersen O (1999) Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet 353(9153):617–622

    Article  CAS  PubMed  Google Scholar 

  15. American Diabetes Association (2014) Standards of medical care in diabetes--2014. Diabetes Care 37(Suppl 1):S14–S80

    Article  Google Scholar 

  16. Weber MA, Schiffrin EL, White WB et al (2014) Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens 16(1):14–26

    Article  Google Scholar 

  17. Emdin CA, Rahimi K, Neal B et al (2015) Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis. JAMA 313(6):603–615

    Article  PubMed  Google Scholar 

  18. (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 317(7160):703–713

    Google Scholar 

  19. Hansson L, Zanchetti A, Carruthers SG et al (1998) Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 351(9118):1755–1762

    Article  CAS  PubMed  Google Scholar 

  20. Patel A; ADVANCE Collaborative Group, MacMahon S (2007) Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 370(9590):829–840

    Google Scholar 

  21. ACCORD Study Group, Cushman WC, Evans GW et al (2010) Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 362(17):1575–1585

    Article  Google Scholar 

  22. Schrier RW, Estacio RO, Esler A, Mehler P (2002) Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int 61(3):1086–1097

    Article  PubMed  Google Scholar 

  23. Howard BV, Roman MJ, Devereux RB et al (2008) Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial. JAMA 299(14):1678–1689

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Cooper-DeHoff RM, Gong Y, Handberg EM et al (2010) Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA 304(1):61–68

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Weber MA, Bakris GL, Jamerson K et al (2010) Cardiovascular events during differing hypertension therapies in patients with diabetes. J Am Coll Cardiol 56(1):77–85

    Article  CAS  PubMed  Google Scholar 

  26. Investigators ONTARGET, Yusuf S, Teo KK et al (2008) Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358(15):1547–1559

    Article  Google Scholar 

  27. Berl T, Hunsicker LG, Lewis JB et al (2005) Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan diabetic nephropathy trial. J Am Soc Nephrol 16(7):2170–2179

    Article  CAS  PubMed  Google Scholar 

  28. SPRINT Research Group, Wright JT Jr, Williamson JD et al (2015) A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 373(22):2103–2116

    Article  Google Scholar 

  29. Sternlicht H, Bakris GL (2016) Hydrochlorothiazide as the diuretic of choice for hypertension: time to kick the habit. J Am Coll Cardiol 67(4):390–391

    Article  CAS  PubMed  Google Scholar 

  30. Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31(7):1281–1357

    Article  CAS  PubMed  Google Scholar 

  31. ALLHAT Officers, ALLHAT Collaborative research Group Coordinators (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288(23):2981–2997

    Article  Google Scholar 

  32. Messerli FH, Bangalore S, Julius S (2008) Risk/benefit assessment of beta-blockers and diuretics precludes their use for first-line therapy in hypertension. Circulation 117(20):2706–2715. discussion 2715

    Article  PubMed  Google Scholar 

  33. Bakris GL, Fonseca V, Katholi RE et al (2004) Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA 292(18):2227–2236

    Article  CAS  PubMed  Google Scholar 

  34. Townsend RR, Machin I, Ren J et al (2016) Reductions in mean 24-hour ambulatory blood pressure after 6-week treatment with canagliflozin in patients with type 2 diabetes mellitus and hypertension. J Clin Hypertens 18(1):43–52

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, ASH Comprehensive Hypertension Center, University of Chicago Medicine, 5841 S. Maryland Ave, MC 1027, Chicago, IL, 60637, USA

    Luke J. Laffin M.D. & George L. Bakris M.D.

Authors
  1. Luke J. Laffin M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. George L. Bakris M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to George L. Bakris M.D. .

Editor information

Editors and Affiliations

  1. Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon

    Adel E. Berbari

  2. Emeritus Professor of Medicine, University of Milano-Bicocca, Monza, Italy

    Giuseppe Mancia

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Laffin, L.J., Bakris, G.L. (2018). Diabetes Mellitus and Hypertension. In: Berbari, A., Mancia, G. (eds) Disorders of Blood Pressure Regulation. Updates in Hypertension and Cardiovascular Protection. Springer, Cham. https://doi.org/10.1007/978-3-319-59918-2_41

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-59918-2_41

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-59917-5

  • Online ISBN: 978-3-319-59918-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation